The effect and proper dose of unfractionated heparin after digital replantation: a prospective study
Not Applicable
- Conditions
- Digital amputations
- Registration Number
- JPRN-UMIN000021991
- Lead Sponsor
- ew Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who decide to withdraw their consent to participate. 2) Patients who have a history of hypersensitivity to UFH component. 3) Patients who have a history of thrombocytopenia caused by heparin. 4) are currently receiving oral administration of anticoagulants or anti-platelet agents. 5) Patients who have a history of blood diseases (such as idiopathic thrombocytopenic purpura.) 6) Patients who have severe hepatic diseases (with AST or ALT levels of 100 U/L or higher). 7) Patients who have severe renal disease (with BUN levels of 25 mg/dL or higher, or serum creatinine levels of 2.0 mg/dL or higher). 8) Patients who are pregnant or lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the success rate at 2 weeks after replantation of amputated digits
- Secondary Outcome Measures
Name Time Method Evaluation of the partial success rate, severity of anemia, blood transfusion volume when needed, and presence or absence of infection.